09-11 SEPTEMBER | WASHINGTON, DC
#PDAFDA
pda.org/PDAFDA2024
REGISTER
BY 17 JULY
TO SAVE UP
TO 20%
PDA/FDA
JOINT REGULATORY
CONFERENCE 2024
Current Good Manufacturing Practice (CGMP):
Leading with Quality and Integrity
Benefi t from the Only FDA Co-Sponsored Pharmaceutical CGMP Conference
Now in its 33rd year, the PDA/FDA Joint Regulatory Conference will offer a comprehensive agenda with
substantive technical sessions and practical case studies that provide insight into the effective application
of Current Good Manufacturing Practice (CGMP).
Concurrent sessions will focus on topics related to quality systems, supply chains, and the use of current
innovations to meet CGMPs.
Topics include:
•
Update on latest CGMP guidance
•
Building CGMP compliant quality systems
•
Conducting robust investigations
•
Assuring effective external supplier selection
and auditing
•
Using current manufacturing technologies
to assure CGMP compliance
•
Avoiding cybersecurity and data integrity risks
•
Upgrading aging facilities
•
Effective implementation of quality
assurance authority
•
De-risking your quality control laboratory
Throughout the conference, industry and regulatory experts will present practical insights and solutions
to help attendees ensure lifecycle drug quality assurance and CGMP compliance at their companies. FDA
regulators will continue to participate as session speakers, moderators, and in interest group discussions.
This conference is the only event where attendees can receive live and highly relevant updates on current
regulatory expectations from Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation
and Research (CBER), Center for Veterinary Medicine (CVM), and Offi ce of Regulatory Affairs (ORA).
Registration is open with early registration pricing through 17 July.
Visit pda.org/PDAFDA2024 to learn more.
